Advanced search
Publication Cover
Journal of Addictive Diseases Volume 22, 2004 - Issue 4
Submit an article Journal homepage
56
Views
14
CrossRef citations to date
0
Altmetric
Original Articles

Guideline Development for Office-Based Pharmacotherapies for Opioid Dependence

David A. Fiellin MD Department of Internal Medicine, Yale University School of Medicine, New Haven, CT, USA
&
Andrea G. Barthwell MD Office of Demond Reduction, White House, Office of National Drug Control Policy, Washington, DC, 20503, USA
Pages 109-120 | Published online: 22 Sep 2008

Citations (14)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (3)

David M. Novick, Edwin A. Salsitz, Herman Joseph & Mary Jeanne Kreek. (2015) Methadone Medical Maintenance: An Early 21st-Century Perspective. Journal of Addictive Diseases 34:2-3, pages 226-237.
Read now
ThomasM. Brady, Sameena Salvucci, LevS. Sverdlov, Alisa Male, Hannah Kyeyune, Emmanuel Sikali, Sameer Desale & Ping Yu. (2005) Methadone Dosage and Retention. Journal of Addictive Diseases 24:3, pages 23-47.
Read now
Thomas R. Kosten & David A. Fiellin. (2004) Buprenorphine for Office-based Practice: Consensus Conference Overview. American Journal on Addictions 13:sup1, pages S1-S7.
Read now

Articles from other publishers (11)

Pooja Lagisetty, Katarzyna Klasa, Christopher Bush, Michele Heisler, Vineet Chopra & Amy Bohnert. (2017) Primary care models for treating opioid use disorders: What actually works? A systematic review. PLOS ONE 12:10, pages e0186315.
Crossref
Nihit Kumar, Zachary N. Stowe, Xiaotong Han & Michael J. Mancino. (2016) Impact of early childhood trauma on retention and phase advancement in an outpatient buprenorphine treatment program. The American Journal on Addictions 25:7, pages 542-548.
Crossref
Richard A. Brown, Erika Litvin Bloom, Jacki Hecht, Ethan Moitra, Debra S. Herman & Michael D. Stein. (2014) A Pilot Study of a Distress Tolerance Treatment for Opiate-Dependent Patients Initiating Buprenorphine. Behavior Modification 38:5, pages 730-759.
Crossref
James E Egan, Julie Netherland, Jonathon Gass, Ruth Finkelstein & Linda Weiss. (2011) Patient Perspectives on Buprenorphine/Naloxone Treatment in the Context of HIV Care. JAIDS Journal of Acquired Immune Deficiency Syndromes 56:Supplement 1, pages S46-S53.
Crossref
Traci Rieckmann, Bret E Fuller, Goal Auzeen Saedi & Dennis McCarty. (2010) Adoption of practice guidelines and assessment tools in substance abuse treatment. Substance Abuse Treatment, Prevention, and Policy 5:1.
Crossref
Michael D. Stein, Debra S. Herman, Malyna Kettavong, Patricia A. Cioe, Peter D. Friedmann, Tahir Tellioglu & Bradley J. Anderson. (2010) Antidepressant treatment does not improve buprenorphine retention among opioid-dependent persons. Journal of Substance Abuse Treatment 39:2, pages 157-166.
Crossref
James E. Egan, Paul Casadonte, Tracy Gartenmann, Judith Martin, Elinore F. McCance-Katz, Julie Netherland, John A. Renner, Linda Weiss, Andrew J. Saxon & David A. Fiellin. (2010) The Physician Clinical Support System-Buprenorphine (PCSS-B): a Novel Project to Expand/Improve Buprenorphine Treatment. Journal of General Internal Medicine 25:9, pages 936-941.
Crossref
Julie Netherland, Michael Botsko, James E. Egan, Andrew J. Saxon, Chinazo O. Cunningham, Ruth Finkelstein, Mark N. Gourevitch, John A. Renner, Nancy Sohler, Lynn E. Sullivan, Linda Weiss & David A. Fiellin. (2009) Factors affecting willingness to provide buprenorphine treatment. Journal of Substance Abuse Treatment 36:3, pages 244-251.
Crossref
Kenneth A. HarrisJrJr, Julia H. Arnsten, Herman Joseph, Joe Hecht, Ira Marion, Patti Juliana & Marc N. Gourevitch. (2006) A 5-year evaluation of a methadone medical maintenance program. Journal of Substance Abuse Treatment 31:4, pages 433-438.
Crossref
Michael D. Stein, Patricia Cioe & Peter D. Friedmann. (2005) Brief report: Buprenorphine retention in primary care. Journal of General Internal Medicine 20:11, pages 1038-1041.
Crossref
Lynn E. Sullivan, David S. Metzger, Paul J. Fudala & David A. Fiellin. (2005) Decreasing international HIV transmission: the role of expanding access to opioid agonist therapies for injection drug users. Addiction 100:2, pages 150-158.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.